Peter C Harris Selected Research

EKB 569

11/2004	Epidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK rats.
11/2003	EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter C Harris Research Topics

Disease

87	Autosomal Dominant Polycystic Kidney (ADPKD) 05/2024 - 05/2002
42	Cysts 05/2024 - 11/2003
28	Polycystic Kidney Diseases (Polycystic Kidney Disease) 05/2024 - 11/2003
15	Disease Progression 02/2024 - 03/2007
15	Autosomal Recessive Polycystic Kidney (Polycystic Kidney Disease, Infantile, Type I) 11/2019 - 03/2002
9	Fibrosis (Cirrhosis) 03/2024 - 11/2003
9	Polycystic liver disease 09/2023 - 03/2007
9	Chronic Kidney Failure (Chronic Renal Failure) 04/2021 - 05/2002
8	Liver Diseases (Liver Disease) 01/2020 - 11/2004
7	Ciliopathies 11/2023 - 09/2009
7	Primary Hyperoxaluria (Oxaluria, Primary) 01/2022 - 06/2007
6	Chronic Renal Insufficiency 10/2023 - 12/2014
6	Cystic Kidney Diseases (Cystic Kidney Disease) 01/2022 - 01/2008
5	Hypercalciuria 03/2022 - 03/2012
4	Nephrolithiasis 07/2021 - 04/2010
4	Body Weight (Weight, Body) 01/2021 - 11/2003
3	Kidney Diseases (Kidney Disease) 01/2024 - 01/2022
3	Renal Insufficiency (Renal Failure) 01/2024 - 03/2012
3	Nephrocalcinosis 03/2022 - 02/2019
3	Inflammation (Inflammations) 01/2022 - 08/2015
3	Meckel syndrome type 1 05/2013 - 02/2006
2	Neoplasms (Cancer) 01/2024 - 09/2012
2	Metabolic Bone Diseases (Osteopenia) 06/2023 - 01/2016
2	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2023 - 01/2021
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2022 - 07/2021
2	Hypercalcemia (Milk Alkali Syndrome) 07/2021 - 03/2012
2	Hypertension (High Blood Pressure) 12/2018 - 08/2003
2	Proteinuria 12/2016 - 01/2016
2	Nephrotic Syndrome (Syndrome, Nephrotic) 11/2015 - 06/2011
2	Pain (Aches) 12/2014 - 06/2010

Drug/Important Bio-Agent (IBA)

38	Proteins (Proteins, Gene)FDA Link 06/2023 - 03/2002
13	TRPP Cation ChannelsIBA 05/2024 - 06/2002
13	Biomarkers (Surrogate Marker)IBA 02/2024 - 03/2012
11	CalciumIBA 01/2022 - 01/2006
7	1-dodecylpyridoxal (PLD)IBA 09/2023 - 06/2010
6	CreatinineIBA 04/2021 - 08/2010
6	Tolvaptan FDA Link 10/2018 - 04/2005
5	Phosphotransferases (Kinase)IBA 11/2023 - 01/2016
4	Vitamin D3 24-HydroxylaseIBA 03/2022 - 03/2012
4	OxalatesIBA 01/2022 - 10/2015
4	polycystic kidney disease 1 proteinIBA 11/2019 - 03/2004
4	Epidermal Growth Factor (EGF)IBA 01/2017 - 11/2003
4	Vasopressins (Vasopressin)IBA 08/2015 - 03/2007
4	DNA (Deoxyribonucleic Acid)IBA 09/2012 - 06/2003
3	EnzymesIBA 01/2023 - 01/2017
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2018
3	polycystic kidney disease 2 proteinIBA 11/2019 - 03/2004
3	Sirolimus (Rapamycin)FDA Link 12/2018 - 01/2016
3	Peptides (Polypeptides)IBA 01/2017 - 03/2007
3	NucleotidesIBA 11/2016 - 05/2002
3	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 02/2015 - 04/2005
2	CationsIBA 05/2024 - 05/2004
2	Histones (Histone)IBA 03/2024 - 01/2021
2	Lysine (L-Lysine)FDA Link 03/2024 - 01/2023
2	RNA (Ribonucleic Acid)IBA 02/2024 - 10/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 03/2020
2	SodiumIBA 01/2023 - 02/2009
2	Adenosine Triphosphate (ATP)IBA 01/2023 - 06/2009
2	Ion Channels (Ion Channel)IBA 01/2023 - 12/2020
2	Vitamin D FDA LinkGeneric 03/2022 - 07/2021
2	1,25-dihydroxyvitamin DIBA 03/2022 - 03/2012
2	GurIBA 01/2022 - 01/2016
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022 - 11/2006
2	Calcitriol (Calcijex)FDA LinkGeneric 07/2021 - 03/2012
2	LipidsIBA 01/2021 - 11/2016
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 03/2020 - 01/2003
2	pasireotideIBA 01/2020 - 01/2015
2	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2020 - 03/2007
2	SaltsIBA 11/2019 - 06/2009
2	Iothalamic Acid (Iotalamic Acid)FDA Link 12/2018 - 05/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2018 - 02/2013
2	MTOR InhibitorsIBA 01/2018 - 06/2015
2	TEMPOIBA 01/2018 - 11/2016
2	adenylyl cyclase 6IBA 01/2017 - 01/2015
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2017 - 01/2016
2	Amino Acids FDA Link 11/2016 - 10/2003
2	diethylstilbestrol monophosphate (PDES)IBA 01/2016 - 01/2010
2	Nonsense Codon (Nonsense Mutation)IBA 03/2015 - 02/2014
2	Adenosine Monophosphate (AMP)IBA 01/2015 - 01/2010
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2014 - 12/2014
2	AlbuminsIBA 12/2014 - 12/2014
2	Telmisartan (Micardis)FDA Link 12/2014 - 12/2014
2	Lisinopril (Prinivil)FDA LinkGeneric 12/2014 - 12/2014
2	Proprotein Convertase 2IBA 10/2013 - 08/2003
2	beta CateninIBA 09/2010 - 03/2004
2	Octreotide (Sandostatin)FDA LinkGeneric 06/2010 - 03/2007
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 06/2010 - 03/2007
2	Adenosine (Adenocard)FDA LinkGeneric 03/2007 - 11/2004
2	Cyclic AMP (AMP, Cyclic)IBA 01/2006 - 04/2004
2	ErbB Receptors (EGF Receptor)IBA 11/2004 - 11/2003
2	EKB 569IBA 11/2004 - 11/2003
2	CL 387785IBA 11/2004 - 11/2003
2	Transforming Growth Factor alpha (TGF-alpha)IBA 11/2004 - 11/2003
2	Urea (Carbamide)FDA LinkGeneric 04/2004 - 11/2003
2	NitrogenIBA 04/2004 - 11/2003
1	ColforsinIBA 05/2024

Therapy/Procedure

15	Therapeutics 01/2020 - 11/2004
4	Kidney Transplantation 01/2024 - 01/2016
3	Transplantation 06/2023 - 01/2016
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2021 - 12/2011